NSE - Delayed Quote INR
Par Drugs and Chemicals Limited (PAR.NS)
102.66
+0.95
+(0.93%)
At close: May 23 at 3:29:27 PM GMT+5:30
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
1,009,289
--
951,065
950,951
742,001
Cost of Revenue
607,015
--
588,826
664,049
498,637
Gross Profit
402,274
--
362,239
286,902
243,364
Operating Expense
198,977
--
160,610
141,329
116,811
Operating Income
203,297
--
201,629
145,573
126,553
Net Non Operating Interest Income Expense
1,235
--
1,250
-613
-2,703
Pretax Income
207,531
--
195,166
150,792
127,032
Tax Provision
53,268
--
50,156
37,451
34,899
Net Income Common Stockholders
154,263
--
145,010
113,341
92,133
Diluted NI Available to Com Stockholders
154,263
--
145,010
113,341
92,133
Basic EPS
12.53
--
11.78
9.21
7.49
Diluted EPS
12.53
--
11.78
9.21
7.49
Basic Average Shares
12,306.39
--
12,304.64
12,304.64
12,304.64
Diluted Average Shares
12,306.39
--
12,304.64
12,304.64
12,304.64
Rent Expense Supplemental
1,413.05
--
1,256
687
447
Total Expenses
805,992
--
749,436
805,378
615,448
Net Income from Continuing & Discontinued Operation
154,263
--
145,010
113,341
92,133
Normalized Income
162,536.21
--
153,279.68
112,090.27
92,142.43
Interest Income
604.83
--
2,321
719
1,839
Interest Expense
15
--
0
24
3,765
Net Interest Income
1,235
--
1,250
-613
-2,703
EBIT
207,546
--
195,166
150,816
130,797
EBITDA
243,728
--
229,527
183,148
163,609
Reconciled Cost of Revenue
607,015
--
588,826
664,049
498,637
Reconciled Depreciation
36,182
--
34,361
32,332
32,812
Net Income from Continuing Operation Net Minority Interest
133,579
--
145,010
113,341
92,133
Total Unusual Items Excluding Goodwill
-11,130
--
-11,130
1,664
-13
Total Unusual Items
-11,130
--
-11,130
1,664
-13
Normalized EBITDA
254,858
--
240,657
181,484
163,622
Tax Rate for Calcs
0
--
0
0
0
Tax Effect of Unusual Items
-2,856.79
--
-2,860.32
413.27
-3.57
3/31/2022 - 5/30/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade